Division of Animal Model, Department of Infectious Diseases, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
PLoS One. 2012;7(11):e49055. doi: 10.1371/journal.pone.0049055. Epub 2012 Nov 16.
BACKGROUND/OBJECTIVE: The CDKAL1 gene is among the best-replicated susceptibility loci for type 2 diabetes, originally identified by genome-wide association studies in humans. To clarify a physiological importance of CDKAL1, we examined effects of a global Cdkal1-null mutation in mice and also evaluated the influence of a CDKAL1 risk allele on body mass index (BMI) in Japanese subjects.
In Cdkal1-deficient (Cdkal1⁻/⁻) mice, we performed oral glucose tolerance test, insulin tolerance test, and perfusion experiments with and without high-fat feeding. Based on the findings in mice, we tested genetic association of CDKAL1 variants with BMI, as a measure of adiposity, and type 2 diabetes in Japanese.
On a standard diet, Cdkal1⁻/⁻ mice were modestly lighter in weight than wild-type littermates without major alterations in glucose metabolism. On a high fat diet, Cdkal1⁻/⁻ mice showed significant reduction in fat accumulation (17% reduction in %intraabdominal fat, P = 0.023 vs. wild-type littermates) with less impaired insulin sensitivity at an early stage. High fat feeding did not potentiate insulin secretion in Cdkal1⁻/⁻ mice (1.0-fold), contrary to the results in wild-type littermates (1.6-fold, P<0.01). Inversely, at a later stage, Cdkal1⁻/⁻ mice showed more prominent impairment of insulin sensitivity and glucose tolerance. mRNA expression analysis indicated that Scd1 might function as a critical mediator of the altered metabolism in Cdkal1⁻/⁻ mice. In accordance with the findings in mice, a nominally significant (P<0.05) association between CDKAL1 rs4712523 and BMI was replicated in 2 Japanese general populations comprising 5,695 and 12,569 samples; the risk allele for type 2 diabetes was also associated with decreased BMI.
Cdkal1 gene deletion is accompanied by modestly impaired insulin secretion and longitudinal fluctuations in insulin sensitivity during high-fat feeding in mice. CDKAL1 may affect such compensatory mechanisms regulating glucose homeostasis through interaction with diet.
背景/目的:CDKAL1 基因是 2 型糖尿病最具复制力的易感基因之一,最初是通过人类全基因组关联研究发现的。为了阐明 CDKAL1 的生理重要性,我们在小鼠中检测了全球 Cdkal1 缺失突变的影响,并评估了 CDKAL1 风险等位基因对日本受试者体重指数 (BMI) 的影响。
在 Cdkal1 缺陷 (Cdkal1⁻/⁻) 小鼠中,我们进行了口服葡萄糖耐量试验、胰岛素耐量试验以及高糖喂养前后的灌注实验。基于在小鼠中的发现,我们测试了 CDKAL1 变体与 BMI(肥胖的衡量标准)和日本 2 型糖尿病的遗传关联。
在标准饮食下,Cdkal1⁻/⁻ 小鼠的体重比野生型同窝仔轻,但葡萄糖代谢没有重大改变。在高脂肪饮食下,Cdkal1⁻/⁻ 小鼠的脂肪积累显著减少(内脏脂肪百分比减少 17%,P=0.023 与野生型同窝仔相比),早期胰岛素敏感性受损程度较轻。高脂肪喂养并没有增强 Cdkal1⁻/⁻ 小鼠的胰岛素分泌(1 倍,与野生型同窝仔的结果相反,1.6 倍,P<0.01)。相反,在后期,Cdkal1⁻/⁻ 小鼠的胰岛素敏感性和葡萄糖耐量受损更为明显。mRNA 表达分析表明,Scd1 可能是 Cdkal1⁻/⁻ 小鼠代谢改变的关键介质。与小鼠的研究结果一致,在包括 5695 名和 12569 名样本的 2 个日本普通人群中,CDKAL1 rs4712523 与 BMI 之间存在显著的(P<0.05)关联;2 型糖尿病的风险等位基因也与 BMI 降低有关。
在高脂肪喂养期间,Cdkal1 基因缺失的小鼠伴随着胰岛素分泌轻度受损和胰岛素敏感性的纵向波动。CDKAL1 可能通过与饮食的相互作用影响调节葡萄糖稳态的这种代偿机制。